The US Food and Drug Administration (FDA) has approved a new medication to treat HIV. The FDA approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) to treat human immunodeficiency virus type 1 (HIV-1) infection. Cabenuva is the first FDA-approved HIV treatment that is injected only once per month. This long-acting medication is meant to replace daily pills for some patients. Currently, the […]
